Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
May 11 EXAS Exact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 10 EXAS Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss
May 10 EXAS UK NICE backs Exact’s Oncotype cancer genomic test
May 10 EXAS Exact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 9 BMRN (BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
May 9 EXAS Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript
May 9 EXAS Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down
May 9 EXAS Q1 2024 Exact Sciences Corp Earnings Call
May 9 EXAS Exact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
May 9 EXAS Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
May 9 EXAS Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript
May 8 EXAS Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
May 8 EXAS Exact Sciences down 17% on quarterly bottom line miss, maintaining 2024 guidance
May 8 EXAS Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
May 8 EXAS Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
May 8 EXAS Exact Sciences GAAP EPS of -$0.60 misses by $0.11, revenue of $637.52M beats by $10.71M
May 8 EXAS Exact Sciences Announces First-Quarter 2024 Results
May 8 BMRN BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
May 8 VYGR Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
May 7 EXAS Exact Sciences Q1 2024 Earnings Preview
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags